In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.
Research funded by NIHR Manchester Biomedical Research Centre (BRC) and the Connected Health Cities Programme has discovered an association between the number of prescriptions for antibiotics and a higher risk of hospital admissions.
Two trials of a new drug have shown that, at low doses, it can ease the often-distressing symptoms of chronic cough with minimal side effects.
In his blog clinical pharmacist, Jake Doherty shares how his six-week NIHR Manchester Biomedical Research Centre (BRC) TRACE-COPD study placement has opened his eyes to new possibilities for a research career.
Professor Paul Dark, Manchester BRC Respiratory Non-fungal Infections Programme Lead and NIHR National Specialty Lead for Critical Care has become an Honorary Fellow of The Royal College of Anaesthetists.
On World Sepsis Day Dr Timothy Felton discusses how Manchester BRC is rising to the challenge of tackling sepsis in the face of the increasing challenge posed by antibiotic resistance.
Researchers at the NIHR Manchester Biomedical Research Centre (BRC) have recently been awarded academic promotions by The University of Manchester.
Manchester BRC has received a £4.4M investment as part of the Department of Health and Social Care’s (DHSC) latest commitment in the fight against antimicrobial (antibiotic) resistance (AMR).